Operational research for Médecins Sans Frontières, HQ in Luxembourg. Research for better care, better access and evidence to advocate. RTs ≠ endorsement
We're starting soon at CHL, Luxembourg! Keep tuned here to follow the discourse with Dr. Oumou Younouss, Dr. Gabriella Ferlazzo of @MSF_access, Joanna Ładomirska, and Dr. Anne Vergison of Lux Health div, moderated by @Ammer_B, organized by the MSF Foundation! @MSF_Luxembourg
5 drug short treatment regimens could produce high rates of sustained treatment success for rifampicin-resistant tuberculosis (RR-TB).
However, the longevity of these regimens will depend upon the rate at which resistance develops to the main components of the treatment & if patients with RR-TB require re-treatment.
Comment @TheLancetInfDis
➡️https://t.co/4HrIYry6MV
#RRTB #TB #EndTB #DRTB